Accordingly, the GO analysis of DEGs indicated their critical enrichment in signaling pathways, including TGFβ signaling, which its dysregulation has been associated with neurodegenerative and cognitive impairment, including Alzheimer’s disease. This evidence concerns the gene TGFB1 and Alzheimer disease.